All the latest articles & insight from our investment writers to inspire your own research and analysis.
Bruce looks at two financial businesses that recently reported Q3 results, both delivering around 7% RoCE. Yet one trades on 5x sales, and the other 0.7x. LSEG and TCAP. The FTSE 100 is up +0.7% in the last 5 days. Nasdaq100 is down -3.4% and the S&P500 was down -2.2%. Much of that sell-off came
Bruce looks at the history of Brompton’s growth, and the trade-offs required to fund expansion. Plus a look at UK banks margin trends and James Cropper CRPR profit warning. The FTSE 100 rose +0.65% in the last 5 days and managed to consolidate above 7,000. Despite US tech stocks reporting a difficult quarter last week,
Michael looks at three features of new market leaders that will show themselves in the new early bull market. It’s goodbye Truss and hello Sunak. It was a success for the Daily Star’s lettuce and a brief rally with Sunak’s appointment. Markets have been anything and with the third Prime Minister of the year (and
Bruce comments on Superdry’s auditor resignation and summarises Q3 trends at UK banks. The FTSE 100 rose above 7000 to 7,057. Nasdaq and the S&P 500 were around +3.0% and +4.5% over the last 5 days. Brent crude remains at mid $94 per barrel. The UK 10Y bond yield fell to 3.62% and the US
Digging deep into stock market sensation Halma’s history, Richard gains clues about the kind of businesses long-term investors should think about owning in an economic blizzard. I have never owned shares in Halma, in fact, I have never considered owning them even though the business has performed extraordinarily well. Halma: Proof that roll-ups can grow
Bruce looks at WISE and AFX, currency traders that are benefiting from the market volatility and rising interest rates. He compares their investment case to the UK banks reporting this week. Despite all the volatility of the last week, the FTSE 100 was actually flat at 6,937 over the last 5 days. The Nasdaq100 and
We’re not alone – if it makes you feel better. Look at the Americans. Of course, you could argue that the market will help when rates are rising according to history: It’s no secret that inflation can have a significant impact on your portfolio. During times of high inflation, it can be difficult to maintain
A few weeks ago, I dug up a statistic that genuinely took my breath away. It came from VC-oriented asset manager Sparkline Capital – “Of the 1,495 US venture deals in the first half of the year, only 4.9% have been down rounds – a historical low!” My own view is that we are only in
Difficult markets prompt Maynard Paton to search for asset-rich shares with depressed ratings. Screening for low price to books and net cash positions leads to house builder Redrow. Difficult market conditions have led to depressed ratings for many asset-flush shares. Hence a new screen to pinpoint companies offering cash-rich balance sheets and market caps below
Two very different US financial personalities believe that US interest rates are rising too fast. No doubt bankers and fund managers are talking their own book, but that doesn’t mean they’re wrong. Stocks covered AT., BDEV, DARK The FTSE 100 failed to consolidate above 7,000 and was down -3.8% last week. The Nasdaq100 was down
Michael looks at several academic studies covering retail investors and what we can learn from them. We last looked at an academic article on trading in the summer of 2020. For a refresher, there were several findings. 1. “Retail investors tend to trade as contrarians after large earnings surprises, both positive and negative” Retail investors
Richard takes a first look at Dechra Pharmaceuticals, a company that has grown profit at a compound annual growth rate of 19% since 2013, yet its share price has halved this year. The financial year ending in June 2022, was Dechra Pharmaceuticals’ 25th anniversary. It was also the year the company joined the FTSE-100 index,
